Painkiller celecoxib slows cancer growth rate
26 May 2016 | By Victoria White, Digital Content Producer
Scientists have found that a widely prescribed painkiller, celecoxib, slows the growth rate of a specific kind of cancer in animal models...
List view / Grid view
26 May 2016 | By Victoria White, Digital Content Producer
Scientists have found that a widely prescribed painkiller, celecoxib, slows the growth rate of a specific kind of cancer in animal models...
26 May 2016 | By Victoria White, Digital Content Producer
A bacteriophage, found in a pond in Connecticut, attacks a common multi-drug resistant bacterial pathogen called Pseudomonas aeruginosa...
25 May 2016 | By Victoria White, Digital Content Producer
The company’s lead product Cilcane (generic name cilengitide) is being repurposed by Iceni as a first-in-class treatment for multiple myeloma...
23 May 2016 | By Victoria White, Digital Content Producer
Researchers have identified a protein 'brake' within Natural Killer cells that controls their ability to destroy their target tumour cells...
23 May 2016 | By Victoria White, Digital Content Producer
Harvard researchers have created a new platform for antibiotic discovery that, they say, may go a long way to solving the crisis of antibiotic resistance...
11 May 2016 | By Victoria White, Digital Content Producer
Pfizer has awarded a total of more than $1 million in funding to five leading advocacy organisations to support metastatic breast cancer scientific research...
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed a drug candidate, Targaprimir-96, that decreases the growth of tumour cells in animal models of triple negative breast cancer...
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed dozens of molecular “warheads” that can detect a key biomarker of cancer and could be developed into a new class of drug candidates...
10 May 2016 | By Victoria White, Digital Content Producer
We discuss Innate Defense Regulator (IDR) technology with Soligenix's Chief Scientific Officer, Dr Oreola Donini, and find out more about SGX942...
9 May 2016 | By Victoria White, Digital Content Producer
In laboratory tests on human cells and mouse models, an experimental therapy was shown to stop treatment-resistant glioblastoma and high-grade gliomas...
4 May 2016 | By Victoria White, Digital Content Producer
By expressing the genes involved in the production of pleuromutilin in a different type of fungus, researchers increased production by more than 2,000%...
28 April 2016 | By Victoria White, Digital Content Producer
Researchers at Lund University have identified a new therapeutic target for the treatment of bacterial infections that regulates the immune response...
28 April 2016 | By Victoria White, Digital Content Producer
Researchers have shown that zinc-oxide nanoparticles can prevent genital herpes virus from entering cells, and help natural immunity to develop...
25 April 2016 | By Victoria White, Drug Target Review
We've created an infographic on the threat of antibiotic resistance, highlighting some of the recommendations made by the Review on Antimicrobial Resistance to date...
22 April 2016 | By Victoria White, Digital Content Producer
AstraZeneca has launched an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline...